Di Lauro L, Fattoruso Si, Giacinti L, ainsi que al. Second-range radiation treatment with FOLFIRI when you look at the clients which have metastatic gastric cancer tumors (MGC) maybe not in the past given fluoropyrimidines. J Clin Oncol. 2009. s (suppl; abstr 4549).

Burtness B, Gibson Meters, Egleston B, et al. Stage II demo from docetaxel-irinotecan combination in state-of-the-art esophageal cancer. Ann Oncol. 2009 Jul. 20(7):1242-8. [QxMD MEDLINE Hook up].

A phase II trial evaluating capecitabine and you can irinotecan because the second line therapy inside the people which have oesophago-gastric cancer tumors that have progressed with the, otherwise inside 90 days away from precious metal-mainly based chemotherapy

Catenacci DVT, Kang YK, Playground H, et al. Margetuximab and pembrolizumab within the people that have prior to now addressed, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): just one-case, phase 1b-dos demonstration. Lancet Oncol. 2020 Aug. 21 (8):1066-1076. [QxMD MEDLINE Connect]. [Full Text].

Doebele Remote-controlled, Drilon Good, Paz-Ares L, Siena S, et al. Entrectinib in people with complex otherwise metastatic NTRK collection-confident strong tumours: provided studies from three phase step 1-2 examples. Lancet Oncol. 2020 Feb. 21 (2):271-282. [QxMD MEDLINE Hook]. [Full Text].

Drilon An effective, Laetsch TW, Kummar S, DuBois SG, ainsi que al. Effectiveness off Larotrectinib in the TRK Blend-Confident Malignant tumors into the Adults and kids. N Engl J Med. 2018 Feb twenty-two. 378 (8):731-739. [QxMD MEDLINE Hook up]. [Complete Text].

Le DT, Durham JN, Smith KN, mais aussi al. Mismatch fix insufficiency predicts reaction out of solid cancers in order to PD-step one blockade. Technology. 2017 Jul twenty-eight. 357 (6349):409-413. [QxMD MEDLINE Hook up].

Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors having Mismatch-Resolve Deficit. N Engl J Med. 2015 Jun twenty five. 372 (26):2509-20. [QxMD MEDLINE Link].

U. Sahin, O

Tabernero J, Yoshino T, Cohn AL, Obermanucirumab as opposed to placebo in conjunction with second-line FOLFIRI inside the clients with metastatic colorectal carcinoma one to evolved during otherwise once earliest-range cures which have bevacizumab, oxaliplatin, and an excellent fluoropyrimidine (RAISE): a beneficial randomised, double-blind, multicentre, stage 3 research. Lancet Oncol. 2015 Can get. 16 (5):499-508. [QxMD MEDLINE Hook up]. [Complete Text message].

Mitani S, Kadowaki S, Komori An effective, Kondoh C, Oze We, Kato K, mais aussi al. A stage II Examination of Changed FOLFOX6 for Complex Gastric Cancer Refractory so you’re able to Important Treatment. Adv Ther. 2020 Jun. 37 (6):2853-2864. [QxMD MEDLINE Hook]. [Complete Text message].

Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A good, mais aussi al. Trifluridine/tipiracil as opposed to placebo within the people having heavily pretreated metastatic gastric cancers (TAGS): a good randomised, double-blind, placebo-regulated, stage step three demonstration. Lancet Oncol. 2018 Late. 19 (11):1437-1448. [QxMD MEDLINE Hook].

Kawazoe A, Ando T, Hosaka H, Fujita J, Koeda K, Nishikawa K, mais aussi al. Security and interest off trifluridine/tipiracil and ramucirumab during the before handled advanced gastric disease: an unbarred-title, single-case, phase 2 demonstration. Lancet Gastroenterol Hepatol. 2021 Mar. 6 (3):209-217. [QxMD MEDLINE Hook]. [Complete Text message].

Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, ainsi que al. A stage 3 study of nivolumab inside the in the past managed complex gastric otherwise gastroesophageal junction cancer (ATTRACTION-2): 2-12 months update investigation. Gastric Cancer tumors. 2020 Get. 23 (3):510-519. [QxMD MEDLINE Hook]. [Complete Text].

Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A good, Asayama Meters, ainsi que al. Regorafenib As well as Nivolumab inside Clients Which have Advanced Gastric or Colorectal Cancer tumors: An open-Title, Dose-Escalation, and Amount-Extension Stage Ib Demo (REGONIVO, EPOC1603). J Clin Oncol. 2020 Jun 20. 38 (18):2053-2061. [QxMD MEDLINE Connect]. [Complete Text message].

Tureci, Grams. Manikhas, mais aussi. al. FAST: a randomised stage II examination of zolbetuximab (IMAB362) along with EOX in place of EOX by yourself getting earliest-range remedy for state-of-the-art CLDN18.2-positive gatric and you may gastro-oesophageal adenocarcinoma. Annals out of Oncology. 2021 May. Vol -619. [Full Text message].

Nivolumab prolonged disease 100 % free emergency from inside the clients that have resected (R0) phase II or III polish hearts phone number esophageal otherwise gastroesophageal junction cancers just who received neoadjuvant chemoradiotherapy along with recurring pathological problem.

Docetaxel 70-85 milligrams/m dos IV to the date 1 plus cisplatin 70-75 mg/m dos IV into the go out step one; all of the 21 d [forty-five, 46, 47] otherwise

Javle MM, Yang Grams, Nwogu Ce, mais aussi al. Capecitabine, oxaliplatin and you will radiotherapy: a level IB neoadjuvant studies getting esophageal cancer tumors that have gene expression studies. Malignant tumors Purchase. 2009 Feb. 27(2):193-2 hundred. [QxMD MEDLINE Hook].

Enzinger Pc, Burtness BA, Niedzwiecki D, Ye X, ainsi que al. CALGB 80403 (Alliance)/E1206: A good Randomized Phase II Study of About three Chemo Regimens In addition to Cetuximab for the Metastatic Esophageal and you will Gastroesophageal Aug 10. 34 (23):2736-42. [QxMD MEDLINE Connect]. [Complete Text].

Albertsson Yards, Johansson B, Friesland S, mais aussi al. Phase II degree on the docetaxel alone all the third week, otherwise per week in combination with gemcitabine in the people having top locally advanced, metastatic, otherwise recurrent esophageal malignant tumors. Med Oncol. 2007. 24(4):407-a dozen. [QxMD MEDLINE Hook].

Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, ainsi que al. Ramucirumab monotherapy for previously treated state-of-the-art gastric or gastro-oesophageal junction adenocarcinoma (REGARD): a major international, randomised, multicentre, placebo-managed, phase step 3 trial. Lancet. 2014 The month of january cuatro. 383(9nine11):31-nine. [QxMD MEDLINE Hook].